Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis

PRoVENT-COVID Study Collaborative Group* ‘PRactice of VENTilation in COVID–19’

Research output: Contribution to journalArticleAcademicpeer-review

148 Downloads (Pure)

Abstract

BACKGROUND: Increasing evidence indicates the potential benefits of restricted fluid management in critically ill patients. Evidence lacks on the optimal fluid management strategy for invasively ventilated COVID-19 patients. We hypothesized that the cumulative fluid balance would affect the successful liberation of invasive ventilation in COVID-19 patients with acute respiratory distress syndrome (ARDS).

METHODS: We analyzed data from the multicenter observational 'PRactice of VENTilation in COVID-19 patients' study. Patients with confirmed COVID-19 and ARDS who required invasive ventilation during the first 3 months of the international outbreak (March 1, 2020, to June 2020) across 22 hospitals in the Netherlands were included. The primary outcome was successful liberation of invasive ventilation, modeled as a function of day 3 cumulative fluid balance using Cox proportional hazards models, using the crude and the adjusted association. Sensitivity analyses without missing data and modeling ARDS severity were performed.

RESULTS: Among 650 patients, three groups were identified. Patients in the higher, intermediate, and lower groups had a median cumulative fluid balance of 1.98 L (1.27-7.72 L), 0.78 L (0.26-1.27 L), and - 0.35 L (- 6.52-0.26 L), respectively. Higher day 3 cumulative fluid balance was significantly associated with a lower probability of successful ventilation liberation (adjusted hazard ratio 0.86, 95% CI 0.77-0.95, P = 0.0047). Sensitivity analyses showed similar results.

CONCLUSIONS: In a cohort of invasively ventilated patients with COVID-19 and ARDS, a higher cumulative fluid balance was associated with a longer ventilation duration, indicating that restricted fluid management in these patients may be beneficial. Trial registration Clinicaltrials.gov ( NCT04346342 ); Date of registration: April 15, 2020.

Original languageEnglish
Article number157
Number of pages12
JournalCritical Care
Volume26
DOIs
Publication statusPublished - 1 Jun 2022

Funding

*PRoVENT-COVID Collaborative Group. Investigators: (in alphabetic order): S. Ahuja1; J.P. van Akkeren2; A.G. Algera3; C.K. Algoe3; R.B. van Amstel3; A. Artigas4; O.L. Baur3; P. van de Berg5; A.E. van den Berg6; D.C.J.J. Bergmans7; D.I. van den Bersselaar3; F.A. Bertens3; A.J.G.H. Bindels5; M.M. de Boer3; S. den Boer8; L.S. Boers3; M. Bogerd3; L.D.J. Bos3; M. Botta3; J.S. Breel9; H. de Bruin3; S. de Bruin3; C.L. Bruna3; L.A. Buiteman–Kruizinga10; O. L. Cremer11; R.M. Determann12; W. Dieperink13; D.A. Dongelmans3; H.S. Franke13; M.S. Galek-Aldridge3; M.J. de Graaff14; L.A. Hagens3; J.J. Haringman16; S.T. van der Heide3; P.L.J. van der Heiden10; N.F.L. Heijnen15; S.J.P. Hiel2; L.L. Hoeijmakers3; L. Hol3,9; M.W. Hollmann9; M.E. Hoogendoorn16; J. Horn3; R. van der Horst17; E.L.K. Ie3; D. Ivanov3; N.P. Juffermans12; E. Kho3; E.S. de Klerk9; A.W.M.M. Koopman-van Gemert18; M. Koopmans12; S. Kucukcelebi3; M.A. Kuiper19; D.W. de Lange11; N. van Mourik3; S.G. Nijbroek3,9; M. Onrust13; E.A.N. Oostdijk20; F. Paulus3,21; C.J. Pennartz3; J. Pillay3,13; L. Pisani3; I.M. Purmer6; T.C.D. Rettig22; J.P. Roozeman3; M.T.U. Schuijt3; M.J. Schultz3,23,24; A. Serpa Neto25; M.E. Sleeswijk26; M.R. Smit3; P.E. Spronk27; W. Stilma3; A.C. Strang28; A.M. Tsonas3; P.R. Tuinman29; C.M.A. Valk3; F.L. Veen-Schra16; L.I. Veldhuis3; P. van Velzen30; W.H. van der Ven9; A.P.J. Vlaar3; P. van Vliet31; P.H.J. van der Voort13; L. van Welie32; H.J.F.T. Wesselink16; H.H. van der Wier-Lubbers16; B. van Wijk3; T. Winters3; W.Y. Wong3; A.R.H. van Zanten32. Institutional and Departmental Affiliations:1Department of Anesthesiology, Pain Management & Perioperative Medicine, Henry Ford Health, Detroit, Michigan, United States;2Department of Intensive Care, Maxima Medical Center, Eindhoven, The Netherlands;3Department of Intensive Care, Amsterdam University Medical Centers, location ‘Academic Medical Center,’ Amsterdam, The Netherlands;4Critical Care Center, Sabadell Hospital, Sabadell, Spain;5Department of Intensive Care, Catharina Hospital, Eindhoven, The Netherlands;6Department of Intensive Care, Haga Hospital, the Hague, The Netherlands;7Department of Intensive Care, Maastricht University Medical Center, Maastricht, The Netherlands;8Department of Intensive Care, Spaarne Hospital, Haarlem, The Netherlands;9Department of Anaesthesiology, Amsterdam University Medical Centers, location ‘Academic Medical Center,’ Amsterdam, The Netherlands;10Department of Intensive Care, Reinier de Graaf Hospital, Delft, The Netherlands;11Department of Intensive Care, University Medical Center Utrecht, Utrecht, The Netherlands;12Department of Intensive Care, OLVG Hospital, location East, Amsterdam, The Netherlands;13Department of Intensive Care, University Medical Center Groningen, Groningen, The Netherlands;14Department of Intensive Care, Sint Antonius Hospital, Nieuwegein, The Netherlands;15Department of Intensive Care, Maastricht University Medical Center, Maastricht, The Netherlands;16Department of Intensive Care, Isala Hospital, Zwolle, The Netherlands;17Department of Intensive Care; Zuyderland Hospital, Heerlen and Sittard, The Netherlands;18Department of Intensive Care ZGT Hospital, Almelo, The Netherlands;19Department of Intensive Care Medical Center Leeuwarden, Leeuwarden, The Netherlands;20Department of Intensive Care; Maasstad Hospital, Rotterdam, The Netherlands;21ACHIEVE, Center of Applied Research Amsterdam University of Applied Sciences, Faculty of Health, Amsterdam, The Netherlands;22Department of Intensive Care Amphia Hospital, Breda, The Netherlands;23Mahidol–Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand;24Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;25Department of Critical Care Medicine, Australian and New Zealand Intensive Care Research Center (ANZIC-RC), Monash University, Melbourne, Australia;26Department of Intensive Care, FlevoHospital, Almere, The Netherlands;27Department of Intensive Care, Gelre Hospital, Apeldoorn and Zutphen, The Netherlands:;28Department of Intensive Care, Rijnstate Hospital, Arnhem, The Netherlands;29Department of Intensive Care, Amsterdam University Medical Centers, location ‘VU Medical Center,’ Amsterdam, The Netherlands;30Department of Intensive Care, Dijklander Hospital, location Hoorn, Hoorn, The Netherlands;31Department of Intensive Care Haaglanden Medical Center, location Westeinde, the Hague, The Netherlands;32Department of Intensive Care Gelderse Vallei Hospital, Ede, The Netherlands.

Fingerprint

Dive into the research topics of 'Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis'. Together they form a unique fingerprint.

Cite this